Sclerosing cholangitis refers to swelling (inflammation), scarring, and destruction of the bile ducts inside and outside of the liver.
Alternative NamesPrimary sclerosing cholangitis; PSC
Causes, incidence, and risk factorsIn this condition, the bile ducts inside and outside the liver become narrowed and scarred.
The cause is often unknown.
The disease is often seen in patients who have:
Genetic factors may also be responsible. Sclerosing cholangitis occurs more often in men than women. This disorder is rare in children.
Sclerosing cholangitis may also be caused by:
The first symptoms are usually fatigue, yellowing of the skin and eyes (jaundice), and itching. However, some people may have no symptoms.
Other symptoms may include:
Some people do not have symptoms, but blood work reveals they have abnormal liver function. The doctor will rule out diseases that cause similar problems. For example, you will be checked for stones in the gallbladder or biliary tract.
Tests that show cholangitis include:
Blood tests include:
Medications that may be used include:
Surgical procedures:
How well patients do varies. The disease tends to get worse over time and most patients develop:
Some patients develop infections of the bile ducts that keep returning. Patients may have chronic liver disease that gets worse, with ascites and varices.
People with this condition have an increased risk of developing cancer of the bile ducts (cholangiocarcinoma). They should be checked on a regular basis (usually each year) with liver scans and blood tests.
ComplicationsGordon FD. Primary sclerosing cholangitis. Surg Clin North Am. 2008;88:1385-1407.
Tung BY, Kowdley KV. Sclerosing cholangitis and recurrent pyogenic cholangitis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, Pa: Saunders Elsevier;2006:chap 65.
The ICD-9 code for primary sclerosing cholangitis is 576.1.
The disease primary sclerosing cholangitis damages to a person's liver. Many people do not experience symptoms. It causes inflammation of the bile ducts both inside and outside the liver.
Payton suffered from Primary sclerosing cholangitis.
primary sclerosing cholangitis (progressive liver disease)
Primary sclerosing cholangitis is a typical example of an autoimmune disease involving the bile ducts
A chronic disease in which it is believed that the immune system fails to recognize the cells that compose the bile ducts as part of the same body, and attempts to destroy them
I've had the largest lobe of my liver removed and have been told that you never grow your liver back but it does regenerate back to full working capacity. If you know someone that is having some of their liver removed be sure to ask if it's because of PSC (primary sclerosing cholangitis). I was never told and had this liver disease for 3 yrs before being told. To read more of this condition and treatments, read... http://www.mayoclinic.com/health/primary-sclerosing-cholangitis/DS00918
Walter Payton died from complications stemming from Primary Sclerosis Cholangitis, or PSC, and bile duct cancer. At first diagnosis, Payton was considered eligible for a liver trans plant, but the cancer dashed this hope. PSC attacks the bile duct causing bile to back up in the liver, thus destroying it.
The full form of PSC can vary based on the context. It may stand for Public Service Commission, which is a government agency responsible for recruitment and oversight of civil service employees. It may also refer to Primary Sclerosing Cholangitis, a chronic liver disease.
If you have Primary Sclerosing Cholangitis (PSC), it's generally advised to limit or avoid alcohol consumption. Alcohol can exacerbate liver damage and complicate the condition, potentially leading to more severe liver issues. It's important to consult your healthcare provider for personalized advice regarding alcohol intake and your specific health situation.
It makes better contact with the wall of the vein than a liquid sclerosing agent; it allows the use of smaller amounts of chemical; and its movement in the vein can be monitored on an ultrasound screen
a method of treating enlarged veins by injecting an irritating chemical called a sclerosing agent into the vein